TY  - GEN
AU  - Orea, María J
AU  - Angulo, Javier C
AU  - González-Corpas, Ana
AU  - Echegaray, David
AU  - Marvá, Marcos
AU  - Lobo, María V T
AU  - Colás, Begoña
AU  - Ropero, Santiago
PY  - 2023
UR  - https://hdl.handle.net/20.500.12105/27280
AB  - Castration-resistant prostate cancer (CRPC) development is the foremost concern after treatment of patients with high risk with locally advanced or metastatic prostate cancer. Androgen receptor (AR) is the main driver of CRPC development, through its...
LA  - eng
PB  - MPDI
KW  - CLDN3
KW  - DNA methylation
KW  - castration-resistant prostate cancer
KW  - prognosis
KW  - prostate
TI  - Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer.
TY  - research article
ER  -